Equity
€40,642 ▲ 1.2%
DORIMED paid out €119,000 in dividends. That is 100% of the 2025 profit.
DORIMED
Lifetime
8 annual accounts with figures on one time axispeak €268,262 (2021)
€169,024▼ 9.7%
peak €167,086 (2021)
€119,497▲ 64.5%
peak €40,642 (2025)
€40,642▲ 1.2%
€122,346▲ 51.9%
peak 1 FTE (2019)
-not published
Board2 names since 2016
1 director
Documentsfilings and deeds
29-12-202533 days before the deadline
2025micro format
Result from €72,656 to €119,497Dividend €119,000Debts from €80,523 to €122,346Cash from €109,082 to €154,791
Key points
from the 2025 annual accountsChecked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 6,712 companies had the same profile as DORIMED has now. Each dot stands for 17 companies, two years later.
95.8%
were still trading
2.2%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,712 companies, not a prediction for DORIMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0668535876
Change of role: , from manager to director
“La médecine est exercée au nom et pour le compte de la société; Les actionnaires doivent apporter à la société…” (deed in French) · General meeting of 06-07-2023 · Gazette deed
Publication in the Belgian Official Gazette
Gazette deed
Incorporation
Founding capital of €18,600, 100 shares, €12,400 paid up · Founder: (comparant) · Appointment: (manager) · published on 30-12-2016 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DORIMED Molenbeek-Saint-Jean | €162,988 | €169,024 | 24.9% | - |
| ISA MOUREAUX Molenbeek-Saint-Jean | €165,650 | €160,993 | 12.4% | - |
| Cabinet de médecine générale Pierrard Nathalie Sambreville | €150,305 | €170,200 | -28.2% | - |
| DR. CHARLOTTE HERREMAN Ardooie | €144,431 | €170,630 | 14.4% | - |
| Dokter Johan Herteleer Bruges | €150,455 | €182,787 | 13.6% | - |
| Dr. Stephanie Traen, huisarts Beveren-Kruibeke-Zwijndrecht | €178,624 | €173,328 | 85.1% | - |
| Dr. Christiaens, huisarts - Dr. De Wit, psychiater Ronse | €190,442 | €167,212 | 93.6% | - |
These companies have the same main activity as DORIMED: general medical practice (NACE 86210). They are comparable in size and age: total assets between €144,000 and €190,000, founded between 2016 and 2018.
Official details
Source: KBO- Status
- Active since 28-12-2016Normal situation
- Activity
- General medical practiceNACE 86210
- Establishment unit
- 2.259.769.1111080 Molenbeek-Saint-Jean, since 28-12-2016
- Financial year end
- 30 June
- Peppol
- Reachable since 19-12-2025
Annual accounts to 30-06-2025
- ≈ €340,000estimated
- €162,988▲ 35.1%
- Employeeson 30-06-2025
- 0
- Filing
- Filed on 29-12-2025, 33 days before the end of the filing period
Insights on DORIMED
DORIMED files the micro format. That format states no turnover. The gross margin rose from €162,682 in 2018 to €169,024 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DORIMED
- What is the company number of DORIMED?
- The company number of DORIMED is 0668.535.876. The VAT number is the same number with BE in front: BE 0668.535.876.
- Where is DORIMED based?
- The registered office is at de Ribaucourtstraat 103, 1080 Molenbeek-Saint-Jean.Company details
- What does DORIMED do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of DORIMED?
- DORIMED is a private limited company (BV).
- When was DORIMED founded?
- DORIMED was founded on 28-12-2016.
- Is DORIMED still active?
- Yes, DORIMED is an active enterprise in the KBO register.
- How many employees does DORIMED have?
- DORIMED had an average of 0.8 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
- What is the turnover of DORIMED?
- The turnover in financial year 2025 is ≈ €340,000. This figure is estimated from the gross margin of €169,024 and 65 comparable companies (NACE 862). It probably lies between €250,000 and €420,000. In financial year 2023 turnover was €292,566.
- Is DORIMED profitable?
- In financial year 2025, DORIMED made a profit of €119,497.
- Where can I find the annual accounts of DORIMED?
- DORIMED filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DORIMED due?
- DORIMED must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.